Home/Crinetics Pharmaceuticals/Camille L. Bedrosian, M.D.
CL

Camille L. Bedrosian, M.D.

Board Member

Crinetics Pharmaceuticals

Roles

Chief Medical OfficeratAmylyx Pharmaceuticals

Crinetics Pharmaceuticals Pipeline

DrugIndicationPhase
Paltusotine (CRN00808)AcromegalyPhase 3
CRN04894Cushing's DiseasePhase 2
CRN04777HyperinsulinismPhase 1
CRN01941Neuroendocrine Tumors (NETs)Preclinical